Dr. Pejman Raeisi-Giglou, DO

Dr. Raeisi-Giglou practices at Pacific Hills Surgery Center in Laguna Hills, California.

Dr. Raeisi-Giglou's NPI, 1689011074, was assigned on May 27, 2013. Dr. Raeisi-Giglou graduated from Touro College of Osteopathic Medicine - New York in 2013. Dr. Raeisi-Giglou holds California license 20A18693.

Dr. Raeisi-Giglou's primary practice is Pacific Hills Surgery Center, at 24022 Calle De La Plata, #180, Laguna Hills, CA 92653. The practice phone is (714) 458-3551.

Dr. Raeisi-Giglou's primary practice is Pacific Hills Surgery Center in Laguna Hills, California. Dr. Raeisi-Giglou is also affiliated with MemorialCare Saddleback Medical Center. The medical group on file is Pacific Cardiovascular Associates (PCA) Medical Group. Dmand AI also links Dr. Raeisi-Giglou to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raeisi-Giglou practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Raeisi-Giglou's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Raeisi-Giglou is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Raeisi-Giglou is licensed in California.

CMS data shows 3,863 Medicare services from Dr. Raeisi-Giglou across 17 procedure codes in 2024, for 607 Medicare patients. Medicare paid $451,957 for them.

CMS counts 607 Medicare patients who saw Dr. Raeisi-Giglou in 2024. The largest group is 65 to 74, with 249 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Raeisi-Giglou's median patient age at 67, with 53% women.

In 2024, Dr. Raeisi-Giglou wrote 1,465 Medicare Part D claims for 391 patients. 83% of them were for generic drugs. CMS names the drug for 1,284 of them, across 22 drugs with 11 or more claims each, at $222,694 in total drug cost. In 2023, CMS named 166 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Raeisi-Giglou for performance year 2024, reported as part of a group. Dr. Raeisi-Giglou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Raeisi-Giglou as offering telehealth. CMS counts 19 procedures of varicose vein removal by Dr. Raeisi-Giglou, more than 56% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Raeisi-Giglou, published from 2016 to 2023. 2022 was the busiest year, with 3. The most frequent topics are Heart Failure, Constriction, Pathologic and Endovascular Procedures. Dr. Raeisi-Giglou has published most often in Curr Probl Cardiol. Dr. Raeisi-Giglou's most frequent co-authors are Ahmad Riad Jabri, MD, Eileen Michelle Hsich, MD and Ashish Kumar.

CMS Open Payments shows 38 general payments to Dr. Raeisi-Giglou from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $301.

Dr. Raeisi-Giglou graduated from Touro College of Osteopathic Medicine - New York in 2013.

Dr. Raeisi-Giglou is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.